Fund Overview of Tata Nifty Midsmall Healthcare Index Fund Direct-idcw
-
₹152.6 CrAUM
-
₹13.32NAV
-
0.47%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Tata Nifty Midsmall Healthcare Index Fund Direct-idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 9.58% | NA | 6.12% |
| 6 Months | 2.83% | NA | 12.92% |
| 1 Year | 11.59% | 11.59% | 6.04% |
Asset Allocation
equities
99.86%other assets or cash equivalents
0.15%Tata Nifty Midsmall Healthcare Index Fund Direct-idcw is one Equity mutual fund offered by Tata Mutual Fund. Launched on 26 Apr 2024, the fund aims Long Term Capital Appreciation. Investment in equity and equity related instruments comprised in Nifty MidSmall Healthcare Index. It manages assets worth ₹152.6 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.47%. Fund Manager Manager Education Fund Manager Manager EducationAbout Tata Nifty Midsmall Healthcare Index Fund Direct-idcw
The portfolio allocation consists of 99.86% in equities, 0.15% in other assets or cash equivalents.Managed by Rakesh Prajapati, it has delivered a return of 11.59% in the last year, a total return since inception of 15.38%.
Individuals often review the best sip plan to create goal-based financial stability.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | 6.92% | 6.81% | 8.05% | 28.30% | 17.27% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,064 | 2.35% | 6.02% | 1.50% | 25.34% | 16.38% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,754 | 5.23% | 11.59% | 12.13% | 26.23% | 16.38% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | 6.85% | 6.60% | 7.16% | 27.21% | 16.24% |
| UTI Healthcare Fund Direct-growth |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
| UTI Healthcare Fund Direct-idcw |
₹1,056 | 6.27% | 8.90% | 9.88% | 26.44% | 15.34% |
More funds from Tata Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Tata India Pharma & Healthcare Fund Regular-growth
|
₹1,229 | 5.61% | 5.05% | -2.63% | 2.78% | 22.46% |
|
Tata India Pharma & Healthcare Fund Direct-growth
|
₹1,229 | 5.74% | 5.42% | -1.93% | 4.30% | 24.27% |
|
Tata India Pharma & Healthcare Fund Regular-idcw
|
₹1,229 | 5.61% | 5.05% | -2.63% | 2.78% | 22.46% |
|
Tata India Pharma & Healthcare Fund Direct-idcw
|
₹1,229 | 5.74% | 5.42% | -1.93% | 4.30% | 24.27% |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-growth
|
₹153 | 7.30% | 9.42% | 2.52% | 10.91% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Direct-growth
|
₹153 | 7.36% | 9.58% | 2.83% | 11.59% | - |
|
Tata Nifty Midsmall Healthcare Index Fund Regular-idcw
|
₹153 | 7.30% | 9.42% | 2.52% | 10.91% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹7,898 | ₹517.71 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-growth |
₹7,898 | ₹580.66 | 23.59% | 14.77% | 15.46% |
| Nippon India Pharma Fund-idcw |
₹7,898 | ₹111.80 | 22.49% | 13.74% | 14.44% |
| Nippon India Pharma Fund Direct-idcw |
₹7,898 | ₹158.92 | 23.59% | 14.77% | 15.46% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,293 | ₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,293 | ₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,293 | ₹23.19 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,293 | ₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,064 | ₹426.36 | 24.04% | 15.16% | 11.90% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,064 | ₹492.05 | 25.34% | 16.38% | 13.14% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Max Healthcare Institute Ltd | Healthcare | 14.54% | ₹22.78 Cr |
| Lupin Ltd | Healthcare | 10.41% | ₹16.49 Cr |
| Lupin Ltd | Healthcare | 10.67% | ₹16.28 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.94% | ₹15.91 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.94% | ₹15.91 Cr |
| Lupin Ltd | Healthcare | 10.20% | ₹15.33 Cr |
| Lupin Ltd | Healthcare | 9.51% | ₹15.10 Cr |
| Lupin Ltd | Healthcare | 9.35% | ₹15.09 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.63% | ₹15.08 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.17% | ₹14.51 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.89% | ₹14.35 Cr |
| Lupin Ltd | Healthcare | 8.86% | ₹14.18 Cr |
| Lupin Ltd | Healthcare | 8.86% | ₹14.18 Cr |
| Lupin Ltd | Healthcare | 8.81% | ₹13.79 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.56% | ₹13.60 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.67% | ₹13.04 Cr |
| Laurus Labs Ltd | Healthcare | 8.00% | ₹12.71 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.05% | ₹12.61 Cr |
| Laurus Labs Ltd | Healthcare | 7.80% | ₹12.35 Cr |
| Lupin Ltd | Healthcare | 7.77% | ₹12.17 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.88% | ₹12.02 Cr |
| Laurus Labs Ltd | Healthcare | 7.44% | ₹12.01 Cr |
| Laurus Labs Ltd | Healthcare | 7.34% | ₹11.21 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹11.06 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹11.06 Cr |
| Laurus Labs Ltd | Healthcare | 7.33% | ₹11.02 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.93% | ₹10.58 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.37% | ₹10.28 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.37% | ₹10.09 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.60% | ₹9.92 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.15% | ₹9.77 Cr |
| Alkem Laboratories Ltd | Healthcare | 6.49% | ₹9.76 Cr |
| Laurus Labs Ltd | Healthcare | 6.23% | ₹9.76 Cr |
| Alkem Laboratories Ltd | Healthcare | 6.16% | ₹9.75 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.94% | ₹9.59 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.99% | ₹9.51 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.00% | ₹9.51 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹9.51 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹9.51 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.10% | ₹9.31 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹9.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹9.25 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.82% | ₹9.11 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.70% | ₹9.05 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.77% | ₹9.04 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.90% | ₹9.00 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.93% | ₹8.92 Cr |
| Laurus Labs Ltd | Healthcare | 5.68% | ₹8.91 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.44% | ₹8.78 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.60% | ₹8.77 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.31% | ₹8.50 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.31% | ₹8.50 Cr |
| Biocon Ltd | Healthcare | 5.19% | ₹8.22 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.25% | ₹8.22 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.03% | ₹8.04 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.03% | ₹8.04 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 4.91% | ₹7.69 Cr |
| Aurobindo Pharma Ltd | Healthcare | 4.87% | ₹7.63 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.73% | ₹7.63 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.84% | ₹7.58 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.74% | ₹7.51 Cr |
| Biocon Ltd | Healthcare | 4.90% | ₹7.47 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.73% | ₹7.41 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.62% | ₹7.34 Cr |
| Biocon Ltd | Healthcare | 4.44% | ₹7.17 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.69% | ₹7.06 Cr |
| Biocon Ltd | Healthcare | 4.40% | ₹6.98 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹6.67 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹6.67 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.32% | ₹6.58 Cr |
| Biocon Ltd | Healthcare | 4.30% | ₹6.47 Cr |
| Ipca Laboratories Ltd | Healthcare | 4.23% | ₹6.45 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.97% | ₹6.28 Cr |
| Biocon Ltd | Healthcare | 3.90% | ₹6.11 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.75% | ₹6.05 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.99% | ₹6.01 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.67% | ₹5.82 Cr |
| Biocon Ltd | Healthcare | 3.55% | ₹5.56 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.55% | ₹5.55 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.43% | ₹5.44 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹5.30 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹5.30 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹5.27 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹5.27 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.29% | ₹5.15 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.26% | ₹5.11 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.13% | ₹5.06 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.13% | ₹4.96 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.23% | ₹4.92 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.21% | ₹4.90 Cr |
| Gland Pharma Ltd | Healthcare | 3.02% | ₹4.73 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.01% | ₹4.72 Cr |
| Abbott India Ltd | Healthcare | 2.91% | ₹4.70 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹4.58 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹4.58 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹4.57 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹4.57 Cr |
| Abbott India Ltd | Healthcare | 2.91% | ₹4.56 Cr |
| Abbott India Ltd | Healthcare | 2.82% | ₹4.51 Cr |
| Abbott India Ltd | Healthcare | 2.82% | ₹4.51 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.79% | ₹4.51 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.84% | ₹4.50 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.99% | ₹4.49 Cr |
| Abbott India Ltd | Healthcare | 2.82% | ₹4.47 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.92% | ₹4.45 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.79% | ₹4.44 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.75% | ₹4.44 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.77% | ₹4.39 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.91% | ₹4.38 Cr |
| Abbott India Ltd | Healthcare | 2.78% | ₹4.36 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.68% | ₹4.32 Cr |
| Gland Pharma Ltd | Healthcare | 2.87% | ₹4.32 Cr |
| Gland Pharma Ltd | Healthcare | 2.71% | ₹4.28 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.67% | ₹4.23 Cr |
| Abbott India Ltd | Healthcare | 2.81% | ₹4.23 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.70% | ₹4.23 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.63% | ₹4.21 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.63% | ₹4.21 Cr |
| Gland Pharma Ltd | Healthcare | 2.60% | ₹4.20 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.65% | ₹4.15 Cr |
| Abbott India Ltd | Healthcare | 2.58% | ₹4.09 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹4.09 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹4.09 Cr |
| Gland Pharma Ltd | Healthcare | 2.55% | ₹4.05 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.45% | ₹3.96 Cr |
| Gland Pharma Ltd | Healthcare | 2.52% | ₹3.96 Cr |
| Gland Pharma Ltd | Healthcare | 2.57% | ₹3.92 Cr |
| Abbott India Ltd | Healthcare | 2.56% | ₹3.91 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.54% | ₹3.88 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.42% | ₹3.84 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.39% | ₹3.79 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.51% | ₹3.77 Cr |
| Wockhardt Ltd | Healthcare | 2.39% | ₹3.74 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.38% | ₹3.73 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.35% | ₹3.73 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.37% | ₹3.71 Cr |
| Syngene International Ltd | Healthcare | 2.28% | ₹3.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹3.68 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.32% | ₹3.67 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹3.65 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.29% | ₹3.59 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹3.57 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹3.57 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.23% | ₹3.56 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.23% | ₹3.56 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.27% | ₹3.55 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.35% | ₹3.53 Cr |
| Wockhardt Ltd | Healthcare | 2.22% | ₹3.53 Cr |
| Syngene International Ltd | Healthcare | 2.25% | ₹3.52 Cr |
| Piramal Pharma Ltd | Healthcare | 2.25% | ₹3.52 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.25% | ₹3.52 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.16% | ₹3.49 Cr |
| Piramal Pharma Ltd | Healthcare | 2.15% | ₹3.47 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.17% | ₹3.44 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.29% | ₹3.44 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.25% | ₹3.43 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.13% | ₹3.39 Cr |
| Wockhardt Ltd | Healthcare | 2.23% | ₹3.35 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.14% | ₹3.35 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.22% | ₹3.34 Cr |
| Wockhardt Ltd | Healthcare | 2.10% | ₹3.32 Cr |
| Global Health Ltd | Healthcare | 2.11% | ₹3.31 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹3.30 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹3.30 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.10% | ₹3.29 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.10% | ₹3.29 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.05% | ₹3.25 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.02% | ₹3.24 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.02% | ₹3.24 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.00% | ₹3.23 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.11% | ₹3.22 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.13% | ₹3.21 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.02% | ₹3.20 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.98% | ₹3.19 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.02% | ₹3.16 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹3.16 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹3.16 Cr |
| Syngene International Ltd | Healthcare | 2.01% | ₹3.15 Cr |
| Global Health Ltd | Healthcare | 1.95% | ₹3.15 Cr |
| Piramal Pharma Ltd | Healthcare | 1.98% | ₹3.15 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.98% | ₹3.14 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.94% | ₹3.10 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.94% | ₹3.10 Cr |
| Global Health Ltd | Healthcare | 1.96% | ₹3.08 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.95% | ₹3.06 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.95% | ₹3.06 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.91% | ₹3.06 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.91% | ₹3.06 Cr |
| Wockhardt Ltd | Healthcare | 1.89% | ₹3.06 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.94% | ₹3.04 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.93% | ₹3.02 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.90% | ₹3.02 Cr |
| Piramal Pharma Ltd | Healthcare | 1.93% | ₹3.02 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.97% | ₹3.01 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.91% | ₹2.99 Cr |
| Global Health Ltd | Healthcare | 1.87% | ₹2.97 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.94% | ₹2.97 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.86% | ₹2.96 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.94% | ₹2.92 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹2.87 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹2.87 Cr |
| Piramal Pharma Ltd | Healthcare | 1.80% | ₹2.85 Cr |
| Global Health Ltd | Healthcare | 1.80% | ₹2.85 Cr |
| Wockhardt Ltd | Healthcare | 1.85% | ₹2.82 Cr |
| Piramal Pharma Ltd | Healthcare | 1.87% | ₹2.81 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.77% | ₹2.77 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.80% | ₹2.74 Cr |
| Syngene International Ltd | Healthcare | 1.76% | ₹2.64 Cr |
| Global Health Ltd | Healthcare | 1.74% | ₹2.62 Cr |
| Natco Pharma Ltd | Healthcare | 1.65% | ₹2.62 Cr |
| Granules India Ltd | Healthcare | 1.71% | ₹2.61 Cr |
| Granules India Ltd | Healthcare | 1.61% | ₹2.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.57% | ₹2.54 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.60% | ₹2.54 Cr |
| Natco Pharma Ltd | Healthcare | 1.66% | ₹2.54 Cr |
| Granules India Ltd | Healthcare | 1.58% | ₹2.50 Cr |
| Piramal Pharma Ltd | Healthcare | 1.61% | ₹2.45 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹2.45 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹2.45 Cr |
| Granules India Ltd | Healthcare | 1.62% | ₹2.43 Cr |
| Granules India Ltd | Healthcare | 1.50% | ₹2.42 Cr |
| Natco Pharma Ltd | Healthcare | 1.51% | ₹2.39 Cr |
| Syngene International Ltd | Healthcare | 1.49% | ₹2.37 Cr |
| Global Health Ltd | Healthcare | 1.55% | ₹2.36 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.55% | ₹2.36 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹2.36 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹2.36 Cr |
| Natco Pharma Ltd | Healthcare | 1.46% | ₹2.35 Cr |
| Pfizer Ltd | Healthcare | 1.45% | ₹2.28 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹2.28 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹2.28 Cr |
| Pfizer Ltd | Healthcare | 1.43% | ₹2.27 Cr |
| Pfizer Ltd | Healthcare | 1.40% | ₹2.26 Cr |
| Granules India Ltd | Healthcare | 1.43% | ₹2.24 Cr |
| Pfizer Ltd | Healthcare | 1.41% | ₹2.23 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹2.22 Cr |
| Poly Medicure Ltd | Healthcare | 1.37% | ₹2.22 Cr |
| Natco Pharma Ltd | Healthcare | 1.47% | ₹2.20 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.39% | ₹2.20 Cr |
| Natco Pharma Ltd | Healthcare | 1.37% | ₹2.19 Cr |
| Natco Pharma Ltd | Healthcare | 1.37% | ₹2.19 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.34% | ₹2.16 Cr |
| Syngene International Ltd | Healthcare | 1.41% | ₹2.15 Cr |
| Natco Pharma Ltd | Healthcare | 1.36% | ₹2.13 Cr |
| Poly Medicure Ltd | Healthcare | 1.35% | ₹2.11 Cr |
| Pfizer Ltd | Healthcare | 1.33% | ₹2.08 Cr |
| Pfizer Ltd | Healthcare | 1.36% | ₹2.07 Cr |
| Natco Pharma Ltd | Healthcare | 1.31% | ₹2.05 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.28% | ₹2.04 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.28% | ₹2.04 Cr |
| Pfizer Ltd | Healthcare | 1.35% | ₹2.03 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.25% | ₹2.02 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.29% | ₹2.02 Cr |
| Poly Medicure Ltd | Healthcare | 1.26% | ₹2.00 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.27% | ₹1.99 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.23% | ₹1.95 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.29% | ₹1.94 Cr |
| Granules India Ltd | Healthcare | 1.21% | ₹1.90 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.21% | ₹1.82 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.11% | ₹1.76 Cr |
| Poly Medicure Ltd | Healthcare | 1.14% | ₹1.71 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.11% | ₹1.67 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.94% | ₹1.49 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.93% | ₹1.42 Cr |
| Poly Medicure Ltd | Healthcare | 0.90% | ₹1.42 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.89% | ₹1.39 Cr |
| Poly Medicure Ltd | Healthcare | 0.86% | ₹1.32 Cr |
| Repo | Unspecified | 0.49% | ₹0.76 Cr |
| Repo | Unspecified | 0.14% | ₹0.22 Cr |
| Repo | Unspecified | 0.11% | ₹0.18 Cr |
| Repo | Unspecified | 0.07% | ₹0.11 Cr |
| Repo | Unspecified | 0.04% | ₹0.06 Cr |
| Repo | Unspecified | 0.03% | ₹0.05 Cr |
| Repo | Unspecified | 0.03% | ₹0.05 Cr |
| Repo | Unspecified | 0.02% | ₹0.03 Cr |
| Repo | Unspecified | 0.01% | ₹0.02 Cr |
| Cash/net Current Assets | Unspecified | 0.01% | ₹0.01 Cr |
| Net Payables | Unspecified | -0.03% | ₹-0.06 Cr |
| Net Payables | Unspecified | -0.07% | ₹-0.07 Cr |
| Net Payables | Unspecified | -0.07% | ₹-0.18 Cr |
| Net Payables | Unspecified | -0.11% | ₹-0.18 Cr |
| Net Payables | Unspecified | -0.11% | ₹-0.18 Cr |
| Net Payables | Unspecified | -0.17% | ₹-0.26 Cr |
| Net Payables | Unspecified | -0.58% | ₹-0.89 Cr |
| Net Payables | Unspecified | -1.48% | ₹-2.38 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹43.11 | 28.30% | 17.27% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹26.03 | 28.30% | 17.27% | - |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹492.05 | 25.34% | 16.38% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹341.86 | 25.34% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹45.41 | 26.23% | 16.38% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹27.35 | 26.23% | 16.38% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹39.76 | 27.21% | 16.24% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹23.19 | 27.21% | 16.24% | - |
| UTI Healthcare Fund Direct-growth |
₹331.99 | 26.44% | 15.34% | - |
| UTI Healthcare Fund Direct-idcw |
₹256.60 | 26.44% | 15.34% | - |
Frequently Asked Questions
Tata Nifty Midsmall Healthcare Index Fund Direct-idcw
What is the current AUM of Tata Nifty Midsmall Healthcare Index Fund Direct-idcw?
As of Tue Mar 31, 2026, Tata Nifty Midsmall Healthcare Index Fund Direct-idcw manages assets worth ₹152.6 crore
How has Tata Nifty Midsmall Healthcare Index Fund Direct-idcw performed recently?
- 3 Months: 9.58%
- 6 Months: 2.83%
What is the long-term performance of Tata Nifty Midsmall Healthcare Index Fund Direct-idcw?
- Since Inception: 15.38%
What is the portfolio composition of Tata Nifty Midsmall Healthcare Index Fund Direct-idcw?
Equity: 99.86%, Others: 0.15%.
Who manages Tata Nifty Midsmall Healthcare Index Fund Direct-idcw?
Tata Nifty Midsmall Healthcare Index Fund Direct-idcw is managed by Rakesh Prajapati from Tata Mutual Fund.
What is the market-cap allocation of Tata Nifty Midsmall Healthcare Index Fund Direct-idcw?
Mid Cap: 66.38%, Small Cap: 33.62%.
Which are the top companies Tata Nifty Midsmall Healthcare Index Fund Direct-idcw has invested in?
- Max Healthcare Institute Ltd – 14.54% of the fund's portfolio
- Lupin Ltd – 10.41% of the fund's portfolio
- Lupin Ltd – 10.67% of the fund's portfolio
- Fortis Healthcare Ltd – 9.94% of the fund's portfolio
- Fortis Healthcare Ltd – 9.94% of the fund's portfolio
Which are the major sectors Tata Nifty Midsmall Healthcare Index Fund Direct-idcw focuses on?
- Healthcare – 901.68% of the fund's portfolio
- Unspecified – -1.67% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





